BD (BDX)
Medical devices and connected systems spanning everyday care, drug delivery, monitoring, and intervention.
$183.03
vs last close+0.03 (+0.01%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 97.23% | 267.90M shares | |
|---|---|---|---|
| 1,470 holders · as of Jun 30, 2026 | |||
| Insiders | 0.22% | 603.2K shares | |
| 31 holders · as of Sep 3, 2026 | |||
| Other | 2.55% | 7.04M shares | |
| remainder | |||
275.54M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
1,470 holders · 267.90M shares · 142 new positions · 691 increased · 551 reduced · 175 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 24.59M | 8.93% | −1.56M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 17.99M | 6.53% | −502.8K | Aug 13, 2026 |
| State Street Corp | 15.00M | 5.44% | +1.18M | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 14.97M | 5.43% | −343.1K | Aug 13, 2026 |
| First Eagle Investment Management, LLC | 13.82M | 5.01% | +1.89M | Aug 24, 2026 |
| Invesco Ltd. | 8.90M | 3.23% | −1.28M | Aug 14, 2026 |
| Massachusetts Financial Services Co /MA/ | 8.65M | 3.14% | −450.5K | Aug 3, 2026 |
| Geode Capital Management, LLC | 8.14M | 2.95% | +1.03M | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.51% | 21.40M | 13G | Apr 29, 2026 |
| State Street Corporation | 5.40% | 15.01M | 13G | Aug 7, 2026 |
| Vanguard Portfolio Management | 5.40% | 15.39M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 165 | $188.49 | 19,720 |
| Aug 13, 2026 | Thomas E. Jr Polendirector, officer: Chairman, CEO and President | Sale | 4,152 | $185.00 | 110,163 |
| Aug 11, 2026 | Roland Goetteofficer: EVP and President, EMEA | Sale | 2,438 | $180.84 | 14,856 |
| Jul 27, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $157.13 | 20,934 |
| Jun 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $152.80 | 21,009 |
| Jun 24, 2026 | Michael David Garrisonofficer: EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $145.66 | 13,172 |
| Jun 10, 2026 | Michael David Garrisonofficer: EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $151.48 | 14,272 |
| Jun 1, 2026 | Thomas E. Jr Polendirector, officer: Chairman, CEO and President | Sale | 2,764 | $146.35 | 110,163 |
| May 26, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 75 | $147.35 | 21,084 |
| Apr 27, 2026 | Michael Feldofficer: EVP, Chief Revenue Officer | Sale | 74 | $151.94 | 21,159 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Thomas H. Kean · NJ07 | Sale | $1,001 – $15,000 | May 21, 2026 | Jun 19, 2026 |